ImmunityBio Stock Jumps As New Bladder Cancer Guideline Boosts Anktiva Use

All NewsMarch 17, 2026

The NCCN adds ImmunityBio Anktiva plus BCG to bladder cancer guidelines, expanding treatment use and boosting outlook.

Importance Rank:

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent